Pharma IQ Members

News

Pharma IQ is an online news source for global pharmaceutical professionals working to treat the world's patients with targeted and effective medical care. The site’s editorial team delivers the latest industry news, thought leadership, and analysis through written articles, webinars, and in-depth market reports. 

16 results
of 2
October 18, 2017 by Pharma IQ
Pharma IQ
Biotech sees swift growth in job openings despite the shrinking level of life sciences vacancies

Tags:
October 10, 2017 by Chanice Henry
Chan
The widespread trend to move away from batch producing medicine is driving the continuous processing technology market to double in size

Tags:
October 3, 2017 by Emily Shirrefs
emily S
With over 2.5million terabytes of data being created a day, the pharmaceutical industry explores how it can get smarter with data management.

Tags:
September 26, 2017 by Sumit Dutta
Sumit Dutta
Arkivum launches Arkivum TRUST enabling the Pharmaceutical, Life Sciences and Health markets to meet core MHRA, FDA GxP and GDPR data integrity guidelines and regulations in a cost-efficient way

Tags: arkivum
September 25, 2017 by George Clinical Representative
Georger
As new knowledge about Acute kidney injury is uncovered, a global, multicentre clinical trial works to revolutionise the treatment of renal failure.

Tags:
September 22, 2017 by Pharma IQ
Pharma IQ
According to a recent deep-dive study by Pharma IQ, drug development approaches a fascinating era as artificial intelligence and other sophisticated technologies emerge to neutralize costly hazards faced in pharma’s R&D pipelines

Tags:
September 19, 2017 by Chanice Henry
Chan
As the globe’s health systems groan under financial pressure, analysts have identified large differences in the amounts European patients pay for generics.

Tags:
September 11, 2017 by Katie Sadler
Katie Sadler
Study reveals UK pharmacy scheme will provide long-term savings for National Health Service (NHS) England

Tags:
September 6, 2017 by Pharma IQ News
Pharma IQ News
As many pharma manufacturers are rushing to discover the next blockbuster treatment in personalized medicine, the US FDA has approved Kymriah – the first chimeric antigen receptor T cell (CAR-T) therapy.

Tags:
August 30, 2017 by Pharma IQ News
Pharma IQ News
Parcom Capital has acquired clinical research organisation Viroclinics Biosciences – which tests around 90 percent of all anti-influenza medications developed worldwide.

Tags:
16 results
of 2